Table 2 Multivariate Cox regression analysis for clinical characteristics and ubiquitination-related gene signatures
From: Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer
Variable | Coefficient | HR | Lower .95 | Upper .95 | P value |
|---|---|---|---|---|---|
Age≥65 | 0.4371 | 1.5482 | 1.0081 | 2.378 | 0.045842 |
Grade 2 | 1.5991 | 4.9487 | 1.1116 | 22.032 | 0.035837 |
Grade 3 | 1.5173 | 4.5599 | 1.0586 | 19.641 | 0.04171 |
Stage II | 0.3142 | 1.3691 | 0.6455 | 2.904 | 0.412779 |
Stage III | 0.9209 | 2.5114 | 1.5128 | 4.169 | 0.00037 |
Stage IV | 1.4898 | 4.4364 | 2.3667 | 8.316 | 3.36E-06 |
High-risk group | 1.1342 | 3.1087 | 1.7123 | 5.644 | 0.000193 |